Tag: Phase 3 Clinical Trial

August 20, 2019

Outlook Therapeutics Finishes Patient Enrollment for NOrse 1 Phase 3 Clinical Trial

Outlook Therapeutics (NASDAQ:OTLK) has announced it has finished enrolling patients in its NORSE i Phase 3 clinical trial evaluating ONS-5010...
August 13, 2019

Innovate Biopharmaceuticals Doses First Patient in Phase 3 Clinical Trial CeD LA3001

Innovate Biopharmaceuticals (NASDAQ:INNT) has announced it has dosed the first patient in its Phase 3 clinical trial, CeD LA 3001....
August 7, 2019

Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials

Rhythm Pharmaceuticals (NASDAQ:RYTM) has announced positive topline results from two Phase 3 clinical trials testing setmelanotide in pro-opiomelanocortin (POMC) and...
July 23, 2019

Diffusion Pharmaceuticals Reports Safety Data for Phase 3 INTACT Study in Glioblastoma Patients

Diffusion Pharmaceuticals (NASDAQ:DFFN) has announced safety data results in its Phase 3 clinical trial of trans sodium crocetinate in inoperable...
March 18, 2019

Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial

Innovate Biopharmaceuticals (NASDAQ:INNT) has announced it has entered into an agreement with SDS Capital Partners II LLC providing for the...
March 5, 2019

Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

Ritter Pharmaceuticals (NASDAQ:RTTR) has announced it has completed enrolment of its first pivotal Phase 3 clinical trial of RP-G28 to...
December 27, 2018

Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy

Retrophin (NASDAQ:RTRX) today announced that the first patient has been dosed in the PROTECT Study, a global, pivotal Phase 3...